Abstract:Objective: To investigate the role of Bcl-XL siRNA in sensitizing ovary cancer cells for TRAIL-induced apoptosis and the underlying mechanisms.Methods: Western blotting analysis was performed to confirm whether Bcl-XL siRNA could effectively down-regulate Bcl-XL protein after SKOV3 cells were transfected with Bcl-XL siRNA and then the cells were treated with TRAIL.Flow cytometry analysis and cell counting were used for assessment of apoptotic rate and survival rate,respectively.Western blotting analysis was performed to determine the changes of apoptosis-related protein in SKOV3 cells.Results: Compared with control group,Bcl-XL siRNA transfection effectively down-regulated the expression of Bcl-XL protein and suppressed the growth of SKOV3 cells;the suppression peaked at 96 h after transfection,being 43.9% that of the control group(P0.05).The apoptotic rate of SKOV3 cells was above 32% after combination treatment with Bcl-XL siRNA and TRAIL protein;the survival rate was 37.8% that of the control group after combination treatment(P0.05).Western blotting analysis demonstrated that Caspase-8,Caspase-9,Bid,Caspase-3,and PARP were obviously activated after combination treatment with Bcl-XL siRNA and TRAIL protein,and the release of cytochrome C was also increased significantly.Conclusion: Bcl-XL siRNA can effectively enhance TRAIL-induced apoptosis in human ovary cancer SKOV3 cells,suggesting it might be a new strategy for ovary cancer therapy.

Bcl-XL Sirna Sensitizes Ovary Cancer Cells in TRAIL-induced Apoptosis